Cramer 5 marker panel for ovarian cancer
Aliases:
This biomarker is also known as:- Cramer 5 marker panel for ovarian cancer
- Cramer 5-marker panel for ovarian cancer
Description…
The PLCO phase III specimens (test half) revealed marker panels produced only marginal improvement over CA 125 alone and, in some case, worse performance. Besides searching for new markers, some ways to improve detection might include: 1) Add epidemiologic variables, and 2) Add in prior markers values.
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Curated |
|---|---|
| HGNC Name: |
Panel Details
The following organs have data associated with this biomarker…
Attributes
| Phase: | 3 |
|---|---|
| QA State: | Curated |
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
No other associated resources found.